These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7792485)

  • 41. Treatment of the cavus foot. Deformity in the pediatric patient with Charcot-Marie-Tooth.
    Olney B
    Foot Ankle Clin; 2000 Jun; 5(2):305-15. PubMed ID: 11232232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cochlear implantation in a patient with deafness induced by Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathies).
    Postelmans JT; Stokroos RJ
    J Laryngol Otol; 2006 Jun; 120(6):508-10. PubMed ID: 16772060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Charcot-Marie-Tooth disease and the cavovarus foot.
    Beals TC; Nickisch F
    Foot Ankle Clin; 2008 Jun; 13(2):259-74, vi-vii. PubMed ID: 18457773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Nosology of Von Graefe-Lindenov syndrome. Study of mental disorders in this genetic neurosensory disease].
    Nehlil J
    Ann Med Psychol (Paris); 1981 Mar; 139(3):352-6. PubMed ID: 7325492
    [No Abstract]   [Full Text] [Related]  

  • 45. External ophthalmoplegia, juvenile parkinsonism and axonal polyneuropathy in two siblings.
    van der Wiel HL; Staal A
    Clin Neurol Neurosurg; 1981; 83(4):247-52. PubMed ID: 6276073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial bilateral vocal cord paralysis and Charcot-Marie-tooth disease type II-C.
    Lacy PD; Hartley BE; Rutter MJ; Cotton RT
    Arch Otolaryngol Head Neck Surg; 2001 Mar; 127(3):322-4. PubMed ID: 11255479
    [No Abstract]   [Full Text] [Related]  

  • 47. Charcot-Marie-Tooth disease type 2 with restless legs syndrome.
    Iannaccone S; Quattrini A; Sferrazza B; Ferini-Strambi L
    Neurology; 2000 Feb; 54(4):1013-4. PubMed ID: 10691014
    [No Abstract]   [Full Text] [Related]  

  • 48. Jean-Martin Charcot and the aging brain.
    Goetz CG
    Arch Neurol; 2002 Nov; 59(11):1821-4. PubMed ID: 12433272
    [No Abstract]   [Full Text] [Related]  

  • 49. Dopa and parkinsonism.
    Br Med J; 1967 Jun; 2(5555):783. PubMed ID: 6029137
    [No Abstract]   [Full Text] [Related]  

  • 50. [Charcot-Marie-Tooth disease type II and dopa-sensitive Parkinson syndrome].
    Dupuis JM; Brucher JM
    Rev Neurol (Paris); 1994 Oct; 150(10):740-1. PubMed ID: 7792485
    [No Abstract]   [Full Text] [Related]  

  • 51. [Type II Charcot-Marie-Tooth and dopa-sensitive Parkinson disease].
    Tranchant C; Ruh D; Warter JM
    Rev Neurol (Paris); 1994; 150(1):72-4. PubMed ID: 7801046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Conduction system disease and Charcot-Marie-Tooth syndrome].
    Rosselot E; Brinck G
    Rev Med Chil; 1989 Aug; 117(8):914-7. PubMed ID: 2519453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Central nervous system signs in X-linked Charcot-Marie-Tooth disease after hyperventilation.
    Srinivasan J; Leventer RJ; Kornberg AJ; Dahl HH; Ryan MM
    Pediatr Neurol; 2008 Apr; 38(4):293-5. PubMed ID: 18358413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Charcot-Marie-Tooth disease associated with Type 2 diabetes mellitus.
    Celik M; Forta H; Parman Y; Bissar-Tadmouri N; Demirkirkan K; Battaloglu E
    Diabet Med; 2001 Aug; 18(8):685-6. PubMed ID: 11553211
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.